Xiaoqiang Kang
Inventor
Stats
- 1 US patents issued
- 10 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 10 US Applications Filed
- 10 Total Citation Count
- Sep 22, 2023 Most Recent Filing
- Jan 13, 2004 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| IMCLONE SYSTEMS INCORPORATED | 1
| 2004
|
| ImClone, LLC | 2
| 2009
|
Inventor Addresses
| Address | Duration |
|---|---|
| Plainsboro, NJ | Jul 08, 04 - Jul 08, 04 |
| Plainsboro, NJ, US | Sep 17, 09 - Feb 27, 24 |
| Plainshoro, NJ, US | Nov 21, 19 - Oct 05, 21 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 8 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 8 |
| C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 11912777 | 2024 | Antibodies binding TNFR2 and uses thereof | 0 |
| 2024/0025,967 | 2024 | RECOMBINANT PROTEIN TARGETING PD-1 AND TGFBETA | 0 |
| 11807683 | 2023 | Antibody binding TIM-3 and use thereof | 0 |
| 11802145 | 2023 | Recombinant protein targeting PD-1 and TGFß | 0 |
| 2023/0212,302 | 2023 | Antibodies Binding TNFR2 and Uses Thereof | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.